Procter & GamblePGCOMMENTJun 09, 2015Stock price when the opinion was issued
As of Jun 08, 2026. Market Open.
Owns neither. Of the two, he'd prefer JNJ. Hesitant to put them in the same basket. With spinoff of healthcare, it's now much more into pharmaceuticals (doing very well) and medical devices. Valuation is not that demanding. Executing well.
PG is a consumer products company. Consumer is in some difficulty, and jury's out as to whether we've seen the worst of that dip.
These consumer stocks are facing inflation. Revenue growth has been low, 3% the last quarter. Margins remain strong, though. Never been cheaper. Pays a 3% dividend. He isn't that bullish on the consumer, but PG is defensive. A good time to buy now, but don't expect a huge return, like 5-10% share appreciation + dividend.
A very high quality global consumer products company. It plays into the whole evolving expanding middle-class in emerging markets. She has chosen Unilever (UN-N) instead because it is much better positioned in emerging markets. Over 57% of their revenues come from that area. Growth is not coming from developed markets; it is coming from emerging markets. This company is restructuring and refocusing, and talking about selling some of their non-core divisions, which could be a catalyst for them. Probably an attractive entry point at this time.